Global Cryopreservation Equipment Market Infographics Description:
- The Global Cryopreservation Equipment Market was valued at US$ 2,146.7 Mn in 2019.
- The target market is projected to reach US$ 6,709.3 Mn in 2029 at a CAGR of 12.2% from 2020 to 2029.
- Based on equipment type, the freezers segment is expected to contribute significant revenue share in the global cryopreservation equipment market and is expected to witness CAGR of over 12.9% in the near future.
- Among cryogen segments, the liquid nitrogen segment is expected to contribute significant revenue share in the global cryopreservation equipment market and is expected to witness CAGR of over 12.4% in the near future.
- Among application segments, sperms, semen, and testicular tissues segment is expected to account for major revenue share and is projected to register a CAGR of over 12.0% in the next coming years, owing to increasing prevalence of acute and chronic diseases across the globe.
- Among all the end user segments, stem cell banks segment is expected to account for major revenue share and is projected to register a CAGR of over 11.9% in the coming years. This is attributed to the increasing demand for advanced equipment used for critical biological sample storage.
- Companies profiled in the report are Thermo Fisher Scientific Inc., General Electric Company, Praxair, Inc., Custom Biogenic Systems Inc., Planer PLC, Chart Biomedical Co. Ltd., Brooks Life Sciences, CryoLogic Pty. Ltd., and Charter Medical.
